Although COVID-19 vaccine shedding has long been a contentious subject, some medical professionals now claim it to be true.
Early in February, Dr. Pierre Kory stated at the Front Line COVID-19 Critical Care Alliance( FLCCC) conference in Phoenix, Arizona, that “Shedding is unfortunately real.” The U.S. Food and Drug Administration( FDA) is aware of this.
Dr. Kory co-founded the FLCCC, a non-profit advocacy group established by doctors to treat postvaccination syndromes, COVID-19, and other conditions. Over a thousand long-COVID and postvaccinated patients have been treated by him, who also co-founded the Leading Edge Clinic.
Fact-checkers have mostly denied shedding based on definition. The U.S. Centers for Disease Control and Prevention (CDC) website defines shedding as the release of live vaccines of viruses, bacteria, and their constituent parts.
MRNA and adenovirus vaccines work similarly to gene therapy products even though they don’t contain live cells.
The FDA warns that there is a risk of shedding in all gene therapy products.
In a 2015 document, The FDA defines shedding as “the release of viral or bacterial gene therapy products… from the patient through one or all of the following ways: excreta (feces), secreta(urine, saliva, nasopharyngeal fluids), or through the skin (pustules, aches, and wounds).
The FDA defines gene therapy products as “all products that mediate their effects by transcription and/or translation of transferred genetic material” in the same document.
This category includes the COVID-19 mRNA and adenovirus vaccines. By causing the body to convert mRNA genetic information into spike proteins, they mediate their effects.
An eye treatment called Luxturna is one of the gene therapy products that is known to cause hair loss. Luxturna delivers eye protein DNA to patients ‘retina cells via an adenovirus carrier.
According to the product's package insert, patients ‘tears have contained the Luxturna adenovirus and its DNA.
According to Dr. Kory, mRNA and the COVID-19 adenovirus vaccines may also cause immunized individuals to release spike proteins or other vaccine components.
For instance, COVID-19 mRNA has been discovered in vaccinated mothers ‘breast milk, suggesting that the vaccine may have been exposed to young children. According to a different study, spike protein, the byproduct of COVID-19 vaccination, can persist in the blood of those who received the vaccine for at least six months.
However, the FDA disputed that COVID mRNA vaccines are covered by the 2015 document.
According to an FDA spokeswoman, the guidance document cited does not apply to COVID-19 vaccines because they are not regulated by the FDA as gene therapy products.
Dr. Kory added that the Pfizer documents contain yet another piece of proof.
If trial participants expose others to the vaccine through inhalation or skin contact, Pfizer's COVID mRNA vaccine protocol requires researchers to report “environmental exposures.”
The protocol also addresses “secondary shedding,” as defined by Dr. Kory and Scott Marsland, co-founders of his clinic. This happens when someone who has already been exposed to the vaccine in the environment exposes someone else.
A female family member or healthcare provider who reports that she is nursing after being exposed to the study intervention (the vaccine) by inhalation or skin contact is “an example of environmental exposure during breastfeeding,” according to Pfizer.
Numerous unfavorable incidents brought on by indirect exposures or exposure to infants while pregnant or nursing have been documented by Pfizer.
22 instances of negative outcomes in infants who had “indirect exposure “to COVID mRNA boosters were documented, indicating exposure other than a direct immunization.
Additionally, the investigators kept an eye on a number of unique adverse event cases. Babies were exposed as a result of breastfeeding in two blood-related adverse events. For the same reason, ten cases of adverse vasculature system events and one case of liver-related adverse events were reported.
Eight respiratory cases and two cases of acute kidney or renal failure also involved breastfeeding or pregnancy-related exposure of infants.
After compiling more than 800 anecdotal reports, Dr. Kory claimed to have noticed a distinct pattern in symptoms that they identified as shedding.
